NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q1 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $5,000 | -16.7% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $6,000 | +20.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | -75.0% | 300 | -75.0% | 0.00% | -83.3% |
| Q3 2020 | $20,000 | -28.6% | 1,200 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $28,000 | +33.3% | 1,200 | 0.0% | 0.01% | +12.5% |
| Q1 2020 | $21,000 | -19.2% | 1,200 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $26,000 | +18.2% | 1,200 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $22,000 | -48.8% | 1,200 | 0.0% | 0.01% | -46.7% |
| Q2 2019 | $43,000 | +7.5% | 1,200 | 0.0% | 0.02% | 0.0% |
| Q1 2019 | $40,000 | +2.6% | 1,200 | 0.0% | 0.02% | -6.2% |
| Q4 2018 | $39,000 | – | 1,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |